With our brand-new facility, BDD is changing small-scale GMP manufacturing.
BDD’s New GMP Facility – Redefining Early-Stage Manufacturing
There’s a lot of waste in traditional GMP manufacturing – too much product, made too slowly. It’s a classic stumbling block in the journey that great products take to reach the market. We’re changing that.
With BDD’s just-in-time, phase-appropriate manufacturing, we make only what you need—no minimum quantity required. Our team has the expertise to pivot and flex to your exact, changing needs.
“One of the best sites we’ve worked with, a truly cohesive team.”
Our GMP manufacturing services can provide non-sterile dosage forms, including:
Manufacturing Services
- Immediate, sustained and modified release tablets
- Dual API release (IR/SR) tablets
- Solid fill capsules
- Powder blends
- Dry granulation
- Radiolabelled products
- Placebo manufacture
- Simple IMPs
GMP Support Services
- Pharmaceutical packaging and labelling- Including bottles, foil sachets and blisters
- Blinded packaging
- Preparation of IMPD for regulatory submissions
Analytical Testing
- Appearance
- Assay and Related Substances (UV, HPLC)
- Blend Homogeneity / Content Uniformity
- Dissolution
- Tablet Hardness / Friability
- Disintegration
- Water Content (Karl Fischer)
Lean Clinical Development™
Using Lean Manufacturing at these crucial early development stages helps you reach Phase I clinical data faster, giving you a competitive edge and powering you towards clinical success sooner.
- Experienced Team
BDD has over 25 years of success conducting early-phase confirmatory clinical trials.
- Founded and Led by Science
Established in 1999 by scientists, BDD has consistently placed great science at the forefront of everything we do.
- Proven Reliability and Track Record
BDD has a superb track record of reliability, supporting clients from formulation through to the clinic, with hundreds of satisfied partners.
- Faster
BDD’s Lean Clinical Development™ approach significantly accelerates traditional development pathways.
- Industry-Leading Recruitment
For decades, BDD has built a robust and effective database of volunteers and patients, achieving an industry-leading 80.2% screening-to-enrolment rate. With BDD, your study starts on time.